DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d342c3/china_freeze_dryin) has announced the addition of the "China Freeze Drying System Industry Report, 2011-2012" report to their offering.
With the rapid development of the pharmaceutical industry in China, the market size of freeze drying equipment continuously expands.
The industry reached RMB2.425 billion in 2009, including the market of cleaning-drying-filling-sealing machines, automatic loading & unloading systems, RABS & isolators, freeze dryer and accessory systems. The market size of the three core equipments (automatic loading & unloading system, RABS & isolator and freeze dryer) was RMB1.4-1.5 billion.
Currently, with the booming development of vacuum freeze drying technology in China, there are several large-scale enterprises qualified with GMP standard in the freeze drying system industry in China, including Shanghai Tofflon Science and Technology Co., Ltd., IMA Life (Beijing) Pharmaceutical Systems Co., Ltd., Shanghai Pudong Freeze Dryer Equipment Co., Ltd., Shanghai Far-East Pharmaceutical Machinery General Factory, and Shanghai Suparnin Pharmaceutical Equipment Co., Ltd.
IMA Life (Beijing) Pharmaceutical Systems Co., Ltd
IMA Life (Beijing) Pharmaceutical Systems Co., Ltd. is a subsidiary of IMA Group in China. IMA Group's freeze drying equipment, related technologies and market share are in a leading position in the industry. IMA Group has 22 factories located in Italy, Germany, UK and China, and its sales network covers more than 70 countries and regions worldwide. In 2010, revenue of IMA Group hit EUR503 million, which basically kept balance with 2009. As for IMA Life (Beijing) Pharmaceutical Systems Co., Ltd., its major business is to export freeze dryer and other pharmaceutical machinery to European and American markets. In 2009, its operating income achieved RMB110 million, up 10.57% YoY.
Shanghai Tofflon Science and Technology Co. Ltd.
Shanghai Tofflon Science and Technology Co. Ltd. is the largest manufacturer of freeze drying equipment in China, whose output has been able to replace certain imported products. In 2010, its operating income achieved RMB480.6171 million, up 56.01% YoY, meanwhile, its total profit reached RMB167.2784 million, a rise of 84.51% YoY. Its revenue of freeze dryer and freeze drying systems equipment registered RMB402 million and RMB54.88 million respectively in 2010, up 45% and 346% YoY respectively. In 2011, its product structure will be further upgraded, with sharply increasing sales revenue of freeze drying systems equipment and continuously enlarged ratios of high-end freeze dryer products such as SIP/CIP.
Shanghai Suparnin Pharmaceutical Equipment Co., Ltd.
Founded in the beginning of 2003, Shanghai Suparnin Pharmaceutical Equipment Co., Ltd. is a joint venture mainly engaged in manufacturing industrial vacuum freeze drying equipment. 70% of Suparnin's products are exported to European and American markets. In the first quarter of 2011, Suparnin won the bid for four freeze dryer projects of Axellia (Taizhou) Pharmaceutical Co., Ltd., Hailing Pharma, Walvax Biotechnology Co., Ltd., and Simcere Dongyuan Pharmaceutical Co., Ltd.
Companies Mentioned:
- Beijing Suyuan Zhongtian Scientific Inc.
- Edwards Tianli (Beijing) Pharmaceutical System
- IMA Group
- IMA Life (Beijing) Pharmaceutical Systems
- Nanjing Guyan Pharmaceutical Equipment
- Shanghai Far-East Pharmaceutical Machinery General Factory
- Shanghai Findnovo Mechanical Technology
- Shanghai Medical Instrument Manufacturing
- Shanghai Pudong Freeze Dryer Equipment
- Shanghai Suparnin Pharmaceutical Equipment
- Shanghai Tofflon Science and Technology
- Shanghai Yucheng Dryer Equipment
- Telstar
- Tianjin IMA Machinery
For more information visit http://www.researchandmarkets.com/research/d342c3/china_freeze_dryin